Distribution of Pseudomonas-Derived Cephalosporinase and Metallo-β-Lactamases in Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Korea
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
The emergence of carbapenem resistance among Pseudomonas aeruginosa is an increasing problem in many parts of the world. In particular, metallo-β-lactamases (MBLs) and AmpC β- lactamases are responsible for high-level resistance to carbapenem and cephalosporin. We studied the diversity and frequency of β-lactamases and characterized chromosomal AmpC β- lactamase from carbapenem-resistant P. aeruginosa isolates. Sixty-one carbapenem-resistant P. aeruginosa isolates were collected from patients in a tertiary hospital in Daejeon, Korea, from January 2011 to June 2014. Minimum inhibitory concentrations (MICs) of four antimicrobial agents were determined using the agar-dilution method. Polymerase chain reaction and sequencing were used to identify the various β-lactamase genes, class 1 integrons, and chromosomally encoded and plasmid-mediated ampC genes. In addition, the epidemiological relationship was investigated by multilocus sequence typing. Among 61 carbapenem-resistant P. aeruginosa isolates, 25 isolates (41.0%) were MBL producers. Additionally, 30 isolates producing PDC (Pseudomonas-derived cephalosporinase)-2 were highly resistant to ceftazidime (MIC50 = 256 μg/ml) and cefepime (MIC50 = 256 μg/ml). Of all the PDC variants, 25 isolates harboring MBL genes showed high levels of cephalosporin and carbapenem resistance, whereas 36 isolates that did not harbor MBL genes revealed relatively low-level resistance (ceftazidime, p < 0.001; cefepime, p < 0.001; imipenem, p = 0.003; meropenem, p < 0.001). The coexistence of MBLs and AmpC β-lactamases suggests that these may be important contributing factors for cephalosporin and carbapenem resistance. Therefore, efficient detection and intervention to control drug resistance are necessary to prevent the emergence of P. aeruginosa possessing this combination of β-lactamases.
Abstract
The emergence of carbapenem resistance among Pseudomonas aeruginosa is an increasing problem in many parts of the world. In particular, metallo-β-lactamases (MBLs) and AmpC β- lactamases are responsible for high-level resistance to carbapenem and cephalosporin. We studied the diversity and frequency of β-lactamases and characterized chromosomal AmpC β- lactamase from carbapenem-resistant P. aeruginosa isolates. Sixty-one carbapenem-resistant P. aeruginosa isolates were collected from patients in a tertiary hospital in Daejeon, Korea, from January 2011 to June 2014. Minimum inhibitory concentrations (MICs) of four antimicrobial agents were determined using the agar-dilution method. Polymerase chain reaction and sequencing were used to identify the various β-lactamase genes, class 1 integrons, and chromosomally encoded and plasmid-mediated ampC genes. In addition, the epidemiological relationship was investigated by multilocus sequence typing. Among 61 carbapenem-resistant P. aeruginosa isolates, 25 isolates (41.0%) were MBL producers. Additionally, 30 isolates producing PDC (Pseudomonas-derived cephalosporinase)-2 were highly resistant to ceftazidime (MIC50 = 256 μg/ml) and cefepime (MIC50 = 256 μg/ml). Of all the PDC variants, 25 isolates harboring MBL genes showed high levels of cephalosporin and carbapenem resistance, whereas 36 isolates that did not harbor MBL genes revealed relatively low-level resistance (ceftazidime, p < 0.001; cefepime, p < 0.001; imipenem, p = 0.003; meropenem, p < 0.001). The coexistence of MBLs and AmpC β-lactamases suggests that these may be important contributing factors for cephalosporin and carbapenem resistance. Therefore, efficient detection and intervention to control drug resistance are necessary to prevent the emergence of P. aeruginosa possessing this combination of β-lactamases.
참고문헌 (33)
- Bae IK, "Molecular epidemiology of Pseudomonas aeruginosa clinical isolates from Korea producing β-lactamases with extended-spectrum activity", Diagn. Microbiol. Infect. Dis, 79, pp.373~377 (2014)
- Cho HH, "Prevalence and genetic analysis of multidrug-resistant Pseudomonas aeruginosa ST235 isolated from a hospital in Korea, 2008-2012", Ann. Clin. Lab. Sci, 43, pp.414~419 (2012)
- Clinical and Laboratory Standards Institute, "Performance standards for antimicrobial susceptibility testing: twentysecond informational supplement", Clinical and Laboratory Standards Institute, ~ (2012)
- Cornaglia G, "Metallo-β-lactamases: a last frontier for β-lactams?", Lancet Infect. Dis, 11, pp.381~393 (2011)
- Grover N, "Therapeutic challenges of ESBLS and AmpC β-lactamase producers in a tertiary care center", Med. J. Armed Forces India, 69, pp.4~10 (2013)
- Huang YT, "Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa carrying metallo-beta-lactamase genes in Taiwan", Diagn. Microbiol. Infect. Dis, 59, pp.211~216 (2007)
- Hu LF, "Stenotrophomonas maltophilia resistance to trimethoprim", sulfamethoxazole mediated by acquisition of sul and dfrA genes in a plasmid-mediated class 1 integron, 2011, pp.37, 230~234
- Jacoby GA, "AmpC β-lactamases", Clin. Microbiol. Rev, 22, pp.161~182 (2009)
- Lister PD, "Antibacterialresistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms", Clin. Microbiol. Rev, 22, pp.582~610 (2009)
- Mammeri H, "Extended-spectrum cephalosporinases in Enterobacteriaceae", Anti-Infect. Agents Med, 6, pp.71~82 (2007)
- Neyestanaki DK, "Determination of extended spectrum β-lactamases, metallo-β-lactamases and AmpC-β-lactamases among carbapenem resistant Pseudomonas aeruginosa isolated from burn patients", Burns, 40, pp.1556~1561 (2014)
- Pasteran F, "Detection of an international multiresistant clone belonging to sequence type 654 involved in the dissemination of KPC-producing Pseudomonas aeruginosa in Argentina", J. Antimicrob. Chemother, 67, pp.1291~1293 (2012)
- Pasteran F, "Novel variant (bla(VIM-11)) of the metallo-{β}-lactamase bla(VIM) family in a GES-1 extendedspectrum-{β}-lactamase-producing Pseudomonas aeruginosa clinical isolate in Argentina", Antimicrob. Agents Chemother, 49, pp.474~475 (2005)
- Pellegrino FL, "Occurrence of a multidrug-resistant Pseudomonas aeruginosa clone in different hospitals in Rio de Janeiro, Brazil", J. Clin. Microbiol, 40, pp.2420~2424 (2002)
- Pérez-Pérez FJ, "Detection of plasmidmediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR", J. Clin. Microbiol, 40, pp.2153~2162 (2002)
- Philippon A, "Plasmid-determined AmpC-type beta-lactamases", Antimicrob. Agents Chemother, 46, pp.1~11 (2002)
- Poirel L, "Multiplex PCR for detection of acquired carbapenemase genes", Diagn. Microbiol. Infect. Dis, 70, pp.119~123 (2011)
- Pollini S, "FIM-1, a new acquired metallo-β-lactamase from a Pseudomonas aeruginosa clinical isolate from Italy", Antimicrob. Agents Chemother, 57, pp.410~416 (2013)
- Poole K., "Pseudomonas aeruginosa: resistance to the max", Front Microbiol, 2, pp.65~ (2011)
- Qing Y, "Outbreak of PER-1 and diversity of β-lactamases among ceftazidime-resistant Pseudomonas aeruginosa clinical isolates", J. Med. Microbiol, 63, pp.386~392 (2014)
- Quale J, "Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates", Antimicrob. Agents Chemother, 50, pp.1633~1641 (2006)
- Raimondi A, "Mutation in Serratia marcescens AmpC β-lactamase producing high-level resistance to ceftazidime and cefpirome", Antimicrob. Agents Chemother, 45, pp.2331~2339 (2001)
- Rodríguez-Martínez JM, "Extended-spectrum cephalosporinases in Pseudomonas aeruginosa", Antimicrob. Agents Chemother, 53, pp.1766~1771 (2009)
- Rodríguez-Martínez JM, "Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa", Antimicrob. Agents Chemother, 53, pp.4783~4788 (2009)
- Sanbongi Y, "Classification of OprD sequence and correlation with antimicrobial activity of carbapenem agents in Pseudomonas aeruginosa clinical isolates collected in Japan", Microbiol. Immunol, 53, pp.361~367 (2009)
- Sevillano E, "First detection of the OXA-40 carbapenemase in P. aeruginosa isolates, located on a plasmid also found in A. baumannii", Pathol. Biol. (Paris), 57, pp.493~495 (2009)
- Tian GB, "PME-1, an extended-spectrum β-lactamase identified in Pseudomonas aeruginosa", Antimicrob. Agents Chemother, 55, pp.2710~2713 (2011)
- Upadhyay S, "Co-existence of Pseudomonas-derived cephalosporinase among plasmid encoded CMY-2 harbouring isolates of Pseudomonas aeruginosa in north India", Indian J. Med. Microbiol, 31, pp.257~260 (2013)
- Viedma E, "Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum β-lactamases GES-1 and GES-5 in Spain", Antimicrob. Agents Chemother, 53, pp.4930~4933 (2009)
- Wang J, "Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals", Int. J. Antimicrob. Agents, 35, pp.486~491 (2010)
- Woodford N, "Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp", Int. J. Antimicrob. Agents, 27, pp.351~353 (2006)
- Wright LL, "Dominance of international ‘high-risk clones’ among metallo-β-lactamase-producing Pseudomonas aeruginosa in the UK", J. Antimicrob. Chemother, 70, pp.103~110 (2015)
- 정윤섭, "Increase in the Prevalence of Carbapenem-Resistant Acinetobacter Isolates and Ampicillin-Resistant Non- Typhoidal Salmonella Species", Infection and Chemotherapy, 46(2), pp.84~93 (2014), 대한감염학회